Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARCHTIS LIMITED Director's Dealing 2021

Nov 30, 2021

64413_rns_2021-11-30_2e58f9cc-240f-4b21-b289-a0c025800499.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity archTIS Limited ABN 79 123 098 671

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Miles Jakeman AM
Date of last notice 3 March 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
N/A
Date of change 24 November 2021
No. of securities held prior to change 1,634,545 Fully Paid Ordinary Shares
360,000 AR9O8 Unlisted Options ($0.20, 13
February2023)
Class AR9O12 Unlisted Options ($0.316, 24 November
2025)
Number acquired 1,000,000 Options
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
The Options were issued for nil cash
consideration, as part of Dr Jakeman’s
remuneration package. Refer to the valuation
included in Schedule 5 of the Notice of Annual
General Meeting released on ASX on 25 October
2021.
No. of securities held after change 1,634,545 Fully Paid Ordinary Shares
360,000 AR9O8 Unlisted Options ($0.20, 13
February 2023)
1,000,000 AR9O12 Unlisted Options ($0.316, 24
November 2025)
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Options.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailed above
traded during a+closed period where prior written clearance
was required?
No
If so, was prior written clearance provided to allow the trade to
proceed during this period?
Not applicable
If prior written clearance was provided, on what date was this
provided?
Not applicable
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3